Affordable Access

Publisher Website

Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives

Authors
Journal
European Journal of Obstetrics & Gynecology and Reproductive Biology
0301-2115
Publisher
Elsevier
Publication Date
Volume
120
Issue
2
Identifiers
DOI: 10.1016/j.ejogrb.2004.10.014
Keywords
  • Overactive Bladder Syndrome
  • Pharmacotherapy
  • Adrenoceptors
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

Abstract The great epidemiological relevance of the overactive bladder (OAB) syndrome and its impact on quality of life of sufferers has encouraged a growing amount of research both in basic science and in clinical fields, with the pharmacological treatment of OAB syndrome being particularly investigated. Recently a new perspective for the use of α-lytic drugs in the treatment of OAB syndrome has been disclosed due to encouraging anecdotal data, and to the identification of different adrenoceptor subtypes in the female lower urinary tract. Starting with a reference picture of female lower urinary tract disorders, the authors review the present pharmacological treatment of female lower urinary tract disorders, and delineate the new perspectives acquired from recent studies of adrenoceptor subtypes.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Overactive bladder syndrome: considerations in pha...

on European Journal of Obstetrics... Jun 01, 2005

Overactive bladder syndrome: considerations in pha...

on Gynäkologisch-geburtshilflich... 2006

Pharmacotherapy of overactive bladder syndrome.

on Expert Review of Clinical Phar... January 2008
More articles like this..